We leverage our third party position to create and disseminate multimedia learning tools that empower patients and their caregivers to better understand diseases and conditions related to angiogenesis and angiogenesis-based treatments.
Regulators, Payers, Policymakers
The Angiogenesis Foundation actively collaborates with organizations and leaders from NIH, FDA, CMS, AHRQ, ASCO, AACR, Colorectal Cancer Alliance, Center for Medical Technology Policy, and Health Technology Assessment International, among other groups.
We hold an annual high-level International Conference on Antiangiogenesis, supported by the Foundation’s continuously maintained knowledge library of major scientific and clinical developments in the angiogenesis field, the largest in the world.
The Angiogenesis Foundation has, to date, successfully completed 512 industry collaborations with 165 companies to: establish awareness about specific diseases and unmet needs; discuss the data supporting the value of emerging validated treatments; identify methods to optimize care pathways.
We convene national and international expert panels comprised of multiple stakeholders (scientists, investigators, association leaders, technology assessors, government representatives, payers, and health policy experts) to roadmap issues, challenges, and key solutions to improve patient outcomes, resulting in white paper recommendations.
Channels used to reach audiences include: television broadcast (The Dr. Oz Show, the Martha Stewart show), the TED website and broadcasts, satellite radio, and print media including the New York Times, the Wall Street Journal, USA Today, Women’s Health, and Oprah Magazine. Finally, the foundation uses interactive campaign websites, Facebook, Twitter, Pinterest, and YouTube to connect with our audiences.